PCN15 PHARMACOECONOMIC ANALYSIS OF EXEMESTANE VERSUS TAMOXIFEN AS ADJUVANT THERAPY FOR PATIENTS WITH EARLY-STAGE ESTROGEN RECEPTOR-POSITIVE BREAST CANCER
Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67253-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)67253-1/fulltext
Title :
PCN15 PHARMACOECONOMIC ANALYSIS OF EXEMESTANE VERSUS TAMOXIFEN AS ADJUVANT THERAPY FOR PATIENTS WITH EARLY-STAGE ESTROGEN RECEPTOR-POSITIVE BREAST CANCER
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67253-1&doi=10.1016/S1098-3015(10)67253-1
First page :
Section Title :
Open access? :
No
Section Order :
480